VXRT vs WAT · rev $28.7M vs P/E 32, rev $1.65B
Vaxart Inc (VXRT) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
VXRT currently screens at market cap $73.0M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the VXRT and WAT stock pages for the full models.
Not investment advice.